Overview / Abstract: |
Per APA Guidelines, treatment goals for schizophrenia include avoiding relapses and exacerbations that can cause immense negative impact on quality of life (QoL). Long-acting injectables (LAIs) are an effective tool for achieving these goals in both acute and chronic phases of illness; however, there is often reluctance to implement their use. A better understanding of the safety and efficacy of LAIs, particularly in comparison to their oral counterparts, can improve treatment decisions for individual patients. This CME Outfitters BriefCase guides clinicians through effective strategies to develop and implement a treatment plan based on patient preferences, phase of illness, and the latest evidence on safety and efficacy of LAIs. - Learning Objectives - At the end of this CE activity, participants should be able to: The following learning objectives pertain only to those requesting CNE or CPE credit: |
Expiration |
Dec 29, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online, Podcast, Webinar / Webcast / Video |
Credits / Hours |
.5 AMA PRA Category 1 Credit™ |
Accreditation |
ACCME, ABIM MOC, ACPE, AANP |
Presenters / Authors / Faculty |
John M. Kane, MD |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck. |
Keywords / Search Terms |
CME Outfitters Schizophrenia, mental illness, mental health, neurology, psychiatry, psych, neuro, psychiatrist, meded, ABIM, MOC, AANP, ACCME, ACPE, free, online, nurse practitioner, pharmacist, neuroscience, psychiatric Free CE CME |